Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.7717/peerj.9965

http://scihub22266oqcxt.onion/10.7717/peerj.9965
suck pdf from google scholar
32999768!7505060!32999768
unlimited free pdf from europmc32999768    free
PDF from PMC    free
html from PMC    free
PDF vom PMID32999768 :   free

suck abstract from ncbi

pmid32999768
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Potential COVID-19 papain-like protease PL(pro) inhibitors: repurposing FDA-approved drugs #MMPMID32999768
  • Kouznetsova VL; Zhang A; Tatineni M; Miller MA; Tsigelny IF
  • PeerJ 2020[]; 8 (ä): e9965 PMID32999768show ga
  • Using the crystal structure of SARS-CoV-2 papain-like protease (PL(pro)) as a template, we developed a pharmacophore model of functional centers of the PL(pro) inhibitor-binding pocket. With this model, we conducted data mining of the conformational database of FDA-approved drugs. This search identified 147 compounds that can be potential inhibitors of SARS-CoV-2 PL(pro). The conformations of these compounds underwent 3D fingerprint similarity clusterization, followed by docking of possible conformers to the binding pocket of PL(pro). Docking of random compounds to the binding pocket of protease was also done for comparison. Free energies of the docking interaction for the selected compounds were lower than for random compounds. The drug list obtained includes inhibitors of HIV, hepatitis C, and cytomegalovirus (CMV), as well as a set of drugs that have demonstrated some activity in MERS, SARS-CoV, and SARS-CoV-2 therapy. We recommend testing of the selected compounds for treatment of COVID-19.
  • ä


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    e9965 ä.8 2020